Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

WASHINGTON—The Federal Communications Commission by a 3-0 vote opened a notice of proposed rulemaking (NPRM) to advance Congress’s mandate to clear a minimum of 100 Megahertz of Upper C-band spectrum ...

From simple text generation to autonomously powering robotic arms on production lines, AI technology offers enterprises a kaleidoscope of new capabilities. So which aspects of AI advancement have ...

The original version of this story appeared in Quanta Magazine. Imagine that someone gives you a list of five numbers: 1, 6, 21, 107, and—wait for it—47,176,870. Can you guess what comes next? If ...

The $12.5 million equity milestone payment is payable by Recursion pursuant to the previously announced agreement under which Rallybio sold its interest in the REV102 program to Recursion for up to ...

Starting in January, Medicare will test out an artificial intelligence (AI) pilot program to decide whether patients get certain procedures covered or not. The Centers for Medicare & Medicaid Services ...